🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the manufacturers of acetaminophen, asserting the corporations concealed alleged dangers that the drug presented to children's cognitive development.

The lawsuit follows a month after Donald Trump advocated an unverified association between taking Tylenol - also known as paracetamol - throughout gestation and autism spectrum disorder in children.

The attorney general is filing suit against the pharmaceutical giant, which once produced the drug, the sole analgesic approved for pregnant women, and Kenvue, which now manufacturers it.

In a declaration, he stated they "misled consumers by gaining financially from suffering and marketing drugs regardless of the risks."

The company says there is no credible evidence tying acetaminophen to autism.

"These companies misled for generations, intentionally threatening millions to increase profits," Paxton, from the Republican party, declared.

Kenvue stated officially that it was "very worried by the perpetuation of misinformation on the security of paracetamol and the possible consequences that could have on the welfare of US mothers and children."

On its website, Kenvue also mentioned it had "regularly reviewed the relevant science and there is insufficient valid information that indicates a verified association between taking paracetamol and autism spectrum disorder."

Associations speaking for physicians and healthcare providers share this view.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the main ingredient in Tylenol - is a restricted selection for women during pregnancy to address discomfort and fever, which can present major wellness concerns if ignored.

"In multiple decades of research on the utilization of paracetamol in pregnancy, zero credible investigations has definitively established that the usage of paracetamol in any stage of gestation results in neurological conditions in young ones," the group commented.

The court filing references current declarations from the Trump administration in claiming the drug is allegedly unsafe.

Recently, Trump raised alarms from public health officials when he advised expectant mothers to "struggle intensely" not to use acetaminophen when ill.

Federal regulators then issued a notice that physicians should think about restricting the usage of acetaminophen, while also mentioning that "a proven link" between the medication and autism in children has remains unverified.

The Health Department head Kennedy, who manages the Food and Drug Administration, had promised in April to initiate "extensive scientific investigation" that would establish the source of autism in a matter of months.

But authorities warned that finding a sole reason of autism spectrum disorder - believed by scientists to be the consequence of a complex mix of genetic and environmental factors - would prove challenging.

Autism spectrum disorder is a category of enduring cognitive variation and condition that impacts how persons perceive and engage with the world, and is identified using physician assessments.

In his lawsuit, the attorney general - a Trump ally who is running for federal office - asserts Kenvue and J&J "deliberately disregarded and tried to quiet the research" around paracetamol and autism.

The case aims to force the companies "remove any promotional materials" that states acetaminophen is reliable for women during pregnancy.

The Texas lawsuit echoes the concerns of a group of parents of minors with autism spectrum disorder and ADHD who took legal action against the manufacturers of acetaminophen in recently.

Judicial authorities threw out the legal action, saying research from the plaintiffs' authorities was not conclusive.